Fundraising FoxProxima Bio
Melbourne, AU · 3 known investors
Find your way into Proxima Bio
Sign up to see every warm intro you have to Proxima Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Proxima Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Proxima Bio is an early-stage biotechnology company developing protein degradation technology to target previously undruggable proteins for treatment of autoimmune conditions and cancers. The company is spun out of WEHI (Walter and Eliza Hall Institute) and based in Melbourne, Australia.
Founders & leadership
J
JaseCo-founder
J
JonCo-founder
JM
John McFarlandExecutive
ZC
Zachary CarpenterNamed on SEC filing
Board
JP
AG
Alex GasnerBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$91.5M disclosed across 1 of 2 rounds · 2024–2026
▶$91.5MraisedJun 2026 · 11 investors · Other Health CareRule 506(b)
▶$91.5MraisedJun 2026 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jason PontinDirector
- Zachary CarpenterExecutive Officer, Director
- Alex GasnerDirector
- John McFarlandExecutive Officer
- Offering amount
- $91.5M
- Amount sold
- $91.5M
- Minimum investment
- $1
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Proxima Bio went on to found or lead other companies.
Frequently asked questions
- What does Proxima Bio do?
- Proxima Bio is an early-stage biotechnology company developing protein degradation technology to target previously undruggable proteins for treatment of autoimmune conditions and cancers. The company is spun out of WEHI (Walter and Eliza Hall Institute) and based in Melbourne, Australia.
- Who founded Proxima Bio?
- Proxima Bio was founded by Jase, Jon.
- Who are Proxima Bio's investors?
- Proxima Bio's investors include Tenmile, Tin Alley Ventures, DCVC (Data Collective).
- How much funding has Proxima Bio raised?
- Proxima Bio has disclosed $91.5M raised across 1 of its 2 known rounds.
- Where is Proxima Bio headquartered?
- Proxima Bio is headquartered in Melbourne, AU.